ARCA Biopharma updates on special dividend related to Oruka merger
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 26 2024
0mins
Should l Buy ?
Special Dividend Announcement: ARCA biopharma has updated the special cash dividend to $1.613 per share, payable on August 28, 2024, to stockholders of record as of August 26, 2024.
Merger Context: This dividend is part of the merger agreement with Oruka Therapeutics, and its amount was determined based on ARCA's net cash exceeding $5 million prior to the merger closing.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
